Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com

Posted by Carolyn Dwyer on Nov 18th, 2024

StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Free Report) in a research note issued to investors on Friday morning. The brokerage issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and set a $6.00 target price on shares of Arcadia Biosciences in a report on Wednesday, August 21st.

Get Our Latest Research Report on RKDA

Arcadia Biosciences Trading Down 24.9 %

Shares of RKDA opened at $2.90 on Friday. The company has a market capitalization of $3.96 million, a PE ratio of -0.68 and a beta of 1.27. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $5.34. The stock’s 50-day moving average price is $3.34 and its two-hundred day moving average price is $3.03.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.